Athenex, Inc.
NASDAQ: ATNX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yiu-Nam Lau F.R.C.P.,
- Employees
- 269
- Headquarters
- Buffalo, United States
- IPO year
- 2017
- Market cap
- $2.3M
- Website
- https://www.athenex.com
Loading ATNX…
Loading profile data…Frequently asked questions about ATNX
What does Athenex, Inc. (ATNX) do?
Athenex, Inc. is a biopharmaceutical company primarily dedicated to the discovery, advancement, and commercialization of therapeutic agents for oncological conditions. Its operations are structured across three distinct platforms: an Oncology Innovation Platform, a Global Supply Chain Platform, and a Commercial Platform. Among its leading produc...
Where does ATNX trade?
Athenex, Inc. (ATNX) trades on the NASDAQ Global Select.
What sector is ATNX in?
Athenex, Inc. (ATNX) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Athenex, Inc.?
Yiu-Nam Lau F.R.C.P., is the chief executive officer of Athenex, Inc. (ATNX).
Where is Athenex, Inc. headquartered?
Athenex, Inc. is headquartered in United States.
Does ATNX pay a dividend?
Athenex, Inc. (ATNX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ATNX go public?
Athenex, Inc. (ATNX) completed its initial public offering in 2017.